• Info
  • Insider Ownership

Insider Trading & Ownership of Gregory Gene Freitag

Location
Alachua, FL
Summary
The estimated net worth of Gregory Gene Freitag is at least $2,420,909 dollars as of 03 Mar 2026. Gregory Gene Freitag is the Director of Axogen, Inc. and owns shares of Axogen, Inc. (AXGN) stock worth about $2.32M. Gregory Gene Freitag is the Director of PDS Biotechnology Corp and owns shares of PDS Biotechnology Corp (PDSB) stock worth about $101.6K.
Signature
/s/ Spencer Brown, as Attorney-in-Fact
All Insider Reports
All Insider Reports

Follow Filing Activity

Follow Gregory Gene Freitag and return when a new Insider Trading filing changes the record on this page.

This uses the existing product follow flow to surface future filing-backed changes without guessing what they mean.

Sign up to save research and follow filings

Quick Takeaways

  • Gregory Gene Freitag has 3 issuer positions tracked on this page.
  • Estimated disclosed ownership value: $2,420,909.
  • Recent insider filing activity is available below.

What Changed

  • Largest disclosed position: Axogen, Inc. ($2,319,295).
  • Past-year value change for that position: .

Why This Matters

  • This page translates Forms 3/4/5 into a quick ownership context before you inspect each transaction row.
  • You can cross-check role, issuer, and filing chronology directly against the SEC source.

Source Evidence

Filed on Form 4

Insider ownership context is sourced from SEC Forms 3, 4, and 5.

See Original Filing

Ownership of Gregory Gene Freitag

Symbol Company Relationship Holdings Value Past Year Net Change Change % Report Period
AXGN Axogen, Inc. Director $2,319,295 04 Jun 2024
PDSB PDS Biotechnology Corp Director $101,614 12 Jan 2026
ZVSA ZyVersa Therapeutics, Inc. Director 11 Jul 2025

Insider Transactions Reported by Gregory Gene Freitag:

Sym Company Class Transaction % Value $ * Price $ Shares Shares After Date Ownership
* An asterisk sign (*) next to the price indicates that the price is likely invalid.